Healthcare

Avacta Announces Positive New Data from the AVA6000 Phase 1 trial Demonstrating Clinically Meaningful Tumor Shrinkage in Patients with Salivary Gland Cancers

Meaningful tumor shrinkage observed in five out of 10 patients with partial and minor responses and 90% disease control rate...

Universal Technical Institute, Inc. to Hold Fiscal First Quarter 2025 Conference Call on Wednesday, February 5, 2025, at 4:30 p.m. ET

PHOENIX, Jan. 15, 2025 /PRNewswire/ -- Universal Technical Institute, Inc. (NYSE: UTI) (the "Company"), a leading workforce solutions provider of transportation,...

Artificial Intelligence (AI) in Medical Imaging Market to Hit USD 4.54 Billion by 2029 with 22.4% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Jan. 15, 2025 /PRNewswire/ -- The global AI medical imaging market, valued at US$ 1.29 billion in 2023,...

Aptevo’s Peter Pavlik, PhD, Chairing Session on “Bi and Multispecific Biologics” at Cambridge Healthcare Institute’s Pep Talk 2025

Also giving an in-session talk titled "Modular Multispecific Biotherapeutics: Rapid Therapeutic Design with the ADAPTIR® Platform," showcasing Aptevo's drug engineering...

error: Content is protected !!